Delivers an AI-powered platform to detect, prioritize, and fix access risks across SaaS, cloud, and on-premise environments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
BalkanID provides an intelligent identity security and access governance platform that helps organizations discover, prioritize, and remediate access sprawl to manage their identity attack surface. The platform leverages data science and automation to streamline access reviews, lifecycle management, and risk remediation across SaaS, cloud, and on-premise environments.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
BalkanID Management Team
Investors
Afore Capital
Clark Golestani
Ely Kahn
John N. Stewart
Pat Condon
Rishi Bhargava
Sure Ventures
Uncommon Capital
Vivek Sodera
BalkanID Valuations & Financials
View real-time NPM data on BalkanID stock including daily BalkanID stock price estimates, valuation history, and historical share price information. Access BalkanID financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track BalkanID pricing across six independent market signals. Looking for private company due diligence data sources on BalkanID? Get in touch to learn more.
Similar Companies
like BalkanID
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Strand Therapeutics
Healthcare & Life Sciences
Develops messenger RNA therapies and precision medicine solutions to create targeted disease treatments using advanced mRNA technology.
Autify
AI-powered platform automating no-code software testing for web and mobile apps, streamlining test creation, execution, and maintenance.
Cybolt
Cybersecurity
Delivers integrated cybersecurity solutions through a unified platform, protecting organizations with managed security and risk management services.
MyOme
Leverages clinical whole-genome sequencing and machine learning bioinformatics to deliver hereditary disease and personalized drug-response insights for healthcare networks.
Kindbody
Healthcare & Life Sciences
Modern fertility clinic providing comprehensive reproductive healthcare services including IVF, egg freezing, and wellness support.
Open Mineral
Digital platform leverages AI to streamline metal trading, procurement, and logistics, connecting suppliers and buyers in the global metals market.
Whiterabbit.ai
Healthcare & Life Sciences
AI-powered healthcare platform uses deep learning to analyze medical images and detect early-stage cancers that human radiologists may miss.
Open8
AI platform that streamlines business communication and automates customer engagement workflows to boost operational efficiency.
FAQ
We have answers
BalkanID stock does not trade on public stock exchanges. BalkanID stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BalkanID stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
BalkanID Stock does not trade on public stock exchanges. In order to sell BalkanID shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
BalkanID does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view BalkanID share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for BalkanID stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BalkanID stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BalkanID stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
BalkanID is a private company and has not had an IPO. There is currently no BalkanID IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to BalkanID IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
